Literature DB >> 24168195

Relationship between left ventricular geometry and soluble ST2 in a cohort of hypertensive patients.

Dike B Ojji1, Lionel H Opie, Sandrine Lecour, Lydia Lacerda, Olusoji Adeyemi, Karen Sliwa.   

Abstract

Left ventricular (LV) hypertrophy (LVH) is classified according to geometric pattern into 4 types: concentric hypertrophy, eccentric hypertrophy, concentric remodeling, and normal geometry. Prevalence of death and cardiovascular complications associated with hypertension depend on the geometric pattern. Although soluble ST2 levels, a novel cardiac biomarker of mechanical strain is increased in hypertension, the relationship with hypertensive LV geometric patterns has not been studied. The authors investigated the relationship between soluble ST2 levels and LV geometric patterns in a cohort of hypertensive patients. LVH was considered present when echocardiographic LV mass index exceeded 49.2 g/m(2.7) in men and 46.2 g/m(2.7) in women. Patients with concentric hypertrophy had higher soluble ST2 levels compared with patients with normal geometry (20.4±8.4 ng/mL vs 14.3±5.4 ng/mL, P<.002). Therefore, soluble ST2 level is not only affected by hypertensive LV, but may be a future biomarker in differentiating concentric hypertrophy from normal geometry in hypertension. ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24168195      PMCID: PMC8033851          DOI: 10.1111/jch.12205

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

Review 1.  The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence.

Authors:  L O'Neill
Journal:  Biochem Soc Trans       Date:  2000-10       Impact factor: 5.407

2.  Left ventricular concentric remodelling and extracardiac target organ damage in essential hypertension.

Authors:  C Cuspidi; G Macca; I Michev; V Fusi; B Severgnini; C Corti; S Meani; C Valerio; C Sala; F Magrini; A Zanchetti
Journal:  J Hum Hypertens       Date:  2002-06       Impact factor: 3.012

3.  Identification of amino-terminal pro-C-type natriuretic peptide in human plasma.

Authors:  T C Prickett; T G Yandle; M G Nicholls; E A Espiner; A M Richards
Journal:  Biochem Biophys Res Commun       Date:  2001-08-24       Impact factor: 3.575

4.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

5.  Correlates of NT-proBNP concentration in patients with essential hypertension in absence of congestive heart failure.

Authors:  Keizo Toda; Yukihito Sato; Tomoko Hara; Kenro Hijiya; Ryutaro Kaneko; Tatuo Okada; Yoshiki Takatsu; Hisayoshi Fujiwara; Toshiaki Iwasaki
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.

Authors:  Y Shigematsu; M Hamada; M Mukai; H Matsuoka; T Sumimoto; K Hiwada
Journal:  J Hypertens       Date:  1995-01       Impact factor: 4.844

7.  Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction.

Authors:  Masahisa Shimpo; David A Morrow; Ellen O Weinberg; Marc S Sabatine; Sabina A Murphy; Elliott M Antman; Richard T Lee
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

Review 8.  Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods.

Authors:  R B Devereux
Journal:  Hypertension       Date:  1987-02       Impact factor: 10.190

9.  T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses.

Authors:  M J Townsend; P G Fallon; D J Matthews; H E Jolin; A N McKenzie
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

10.  "Echocardiography in Nigeria: use, problems, reproducibility and potentials".

Authors:  Okechukwu S Ogah; Ademola T Adebanjo; Adedeji S Otukoya; Tarwanger J Jagusa
Journal:  Cardiovasc Ultrasound       Date:  2006-03-21       Impact factor: 2.062

View more
  9 in total

Review 1.  Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world.

Authors:  Dike Ojji; Elena Libhaber; Kim Lamont; Friedrich Thienemann; Karen Sliwa
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 2.  Biomarkers in hypertension and their relationship with myocardial target-organ damage.

Authors:  Yang Xue; Navaid Iqbal; Jeffrey Chan; Alan Maisel
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

3.  NT-pro BNP and plasma-soluble ST2 as promising biomarkers for hypertension, hypertensive heart disease and heart failure in sub-Saharan Africa.

Authors:  Anastase Dzudie; Bonaventure Suiru Dzekem; Andre Pascal Kengne
Journal:  Cardiovasc J Afr       Date:  2017 Nov/Dec       Impact factor: 1.167

4.  A functional variant in ST2 gene is associated with risk of hypertension via interfering MiR-202-3p.

Authors:  Fangqin Wu; Lu Li; Qiang Wen; Jinhua Yang; Zhuyue Chen; Peng Wu; Meian He; Xiaomin Zhang; Tangchun Wu; Longxian Cheng
Journal:  J Cell Mol Med       Date:  2017-01-25       Impact factor: 5.310

5.  Left ventricular mass estimation by different partition values in a large population of black hypertensive subjects.

Authors:  Dike B Ojji; Elena Libhaber; Jacob Alfa; Ngabea Murtala; Bolaji Abdullahi; Ada Nwankwo; Anita Nnamonu; Sliwa Karen
Journal:  Health Sci Rep       Date:  2018-01-25

6.  Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome.

Authors:  Vera Celic; Anka Majstorovic; Biljana Pencic-Popovic; Aleksandra Sljivic; Natalia Lopez-Andres; Ignacio Roy; Elena Escribano; Maite Beunza; Amaia Melero; Federico Floridi; Laura Magrini; Rossella Marino; Gerardo Salerno; Patrizia Cardelli; Salvatore Di Somma
Journal:  Ann Lab Med       Date:  2016-11       Impact factor: 3.464

7.  Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure.

Authors:  Dike B Ojji; Sandrine Lecour; Olusoji M Adeyemi; Karen Sliwa
Journal:  Vasc Health Risk Manag       Date:  2017-08-16

8.  Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients.

Authors:  Anca Daniela Farcaş; Mihaela Mocan; Florin Petru Anton; Mocan-Hognogi Larisa Diana; Roxana Mihaela Chiorescu; Mirela Anca Stoia; Camelia Larisa Vonica; Cerasela Mihaela Goidescu; Luminița Animarie Vida-Simiti
Journal:  Dis Markers       Date:  2020-02-06       Impact factor: 3.434

Review 9.  Biomarkers in the management of acute heart failure: state of the art and role in COVID-19 era.

Authors:  Aneta Aleksova; Gianfranco Sinagra; Antonio P Beltrami; Alessandro Pierri; Federico Ferro; Milijana Janjusevic; Giulia Gagno
Journal:  ESC Heart Fail       Date:  2021-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.